30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered outdated |
30/04/2017 |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
CIM |
Registered |
30/04/2017 |
HEBERBIOVAC HB vaccine to reference material. |
CIGB |
Registered |
28/04/2017 |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
FINLAY |
Registered outdated |
27/04/2017 |
Hepatotoxicity by drugs |
CenQfal |
Registered |
17/02/2017 |
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
CIM |
Registered |
17/02/2017 |
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
17/02/2017 |
Paclitaxel/Radiotherapy/Cisplatino for cervical cancer |
SSA |
Registered |
16/02/2017 |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CIGB |
Registered |
16/02/2017 |
CENTAURO-6 Study |
CIGB |
Registered |
16/02/2017 |
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |
HGM |
Registered |
10/02/2017 |
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
CNCMA |
Registered |
03/02/2017 |
Phase I/II trial with the mutein no alfa of IL-2 |
CIM |
Registered outdated |
01/02/2017 |
NeuroEPO in patients with Parkinson disease stage II-III |
CIM |
Registered |
01/02/2017 |
NeuroEPO in patients with Mild-Moderate Alzheimer's disease |
CIM |
Registered |
27/01/2017 |
Pharmacovigilance-VALERGEN-Asthma |
BIOCEN |
Registered |
26/01/2017 |
ESAR-814 Study |
CIGB |
Registered |
05/01/2017 |
HEBERFERON in renal cell carcinoma |
CIGB |
Registered outdated |
29/12/2016 |
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain |
FINLAY |
Registered |
27/12/2016 |
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
CPN |
Registered |